Open Access Article
This Open Access Article is licensed under a Creative Commons Attribution-Non Commercial 3.0 Unported Licence

Recent advances in enyne cycloisomerization using N-heterocyclic carbene gold complexes

Ahmed Hassoon Mageed *
The University of Kufa, Faculty of Science, Department of Chemistry, P. O. Box 21, An-Najaf 54001, Iraq. E-mail: ahmedh.alameri@uokufa.edu.iq

Received 12th August 2025 , Accepted 16th September 2025

First published on 30th September 2025


Abstract

Since the pioneering discovery of N-heterocyclic carbene (NHC)-gold complexes, extensive research has propelled the field of homogeneous gold catalysis into new frontiers. Among the most dynamic and synthetically valuable applications is the Au(NHC)-catalyzed cycloisomerization of enynes. This review highlights recent advances in this rapidly evolving area, with a focus on the cyclization of 1,6-enynes, 1,5-enynes, and other 1,n-enyne systems. Special attention is given to the oxidative cyclization of enynes, which further expands the chemical space accessible via gold catalysis. Mechanistic insights are critically examined, revealing how NHC ligands modulate the reactivity, selectivity, and stability of gold centers. Through the lens of both mechanistic understanding and catalytic performance, this review underscores the growing importance of Au(NHC) complexes in the efficient and selective construction of complex molecular frameworks.


image file: d5ra05920h-p1.tif

Ahmed Hassoon Mageed

Ahmed Hassoon Mageed earned his B.Sc. degree from the University of Kufa in 2008, followed by an M.Sc. in 2010. He completed his PhD in 2018 at the University of Western Australia, under the supervision of Prof. Murray Baker. In 2011, he began his career as a Lecturer at the University of Kufa, where he is currently an Assistant Professor in the Department of Chemistry. His research focuses on organic synthesis, organometallic chemistry, and medicinal chemistry.


Introduction

In 1968, Öfele and Wanzlick introduced the pioneering research on the first N-heterocyclic carbene (NHC) complexes.1,2 Subsequently, many NHC-metal complexes have been reported.3–11 NHCs display remarkable attributes, such as a robust σ-donor capacity and the capability to establish enduring bonds with main-group and transition metals. In contrast to phosphines, NHCs exhibit improved thermal stability.3,12–14 These beneficial properties have propelled the extensive adoption of NHCs as ligands for coordinating various hard and soft transition metals in modern scientific investigations.3,8,15–19

N-Heterocyclic carbenes have emerged as versatile ligands for coordinating transition metals, finding diverse applications in catalysis, materials science, and medicinal chemistry.9,20–29 Among these transition metals, gold has attracted considerable interest as a distinctive host for NHC coordination due to its unique reactivity and intriguing characteristics.30–35 NHC-gold complexes have demonstrated notable catalytic efficacy in a range of synthetic processes, encompassing carbon–carbon bond formation, cross-coupling reactions, and small-molecule activations.9,36–41

In the early 2000s, the first synthesis of NHC-gold complexes marked a significant advancement in the field of gold chemistry.42–45 These complexes commonly consist of a chelating NHC ligand bound to a central gold atom, resulting in stable and precisely defined configurations.30,32,35,45–48 The potent σ-donating properties of NHC ligands, in conjunction with the soft Lewis acidity of gold, lead to distinctive reactivity patterns and bonding interactions.22,30,36,49,50 These features have positioned them as valuable materials in homogeneous catalysis, enabling the creation of efficient and selective transformations.37,39,40,50–52 Furthermore, NHC-gold complexes have enabled various organic transformations, such as enyne cycloisomerizations, propargylic ester rearrangements, hydroaminations, and hydrations.53–65

The significant advancements in enyne cycloisomerization using various metal catalysts are highlighted in Fig. 1. It began in 1984 with the first reported metal-catalyzed enyne cycloisomerization by Trost's research group using Pd(II).66 In 1988, Grigg's research group introduced Rh(I)-catalyzed enyne cycloisomerization.67 The field advanced further in 2000, with Trost's report on Ru(II)-catalyzed enyne cycloisomerization,68 followed by Echavarren's discovery of Pt(II)-catalysis in 2001.69 In 2004, Echavarren also pioneered the use of Au(I) catalysts for enyne cycloisomerization, marking a significant breakthrough.70 The next major advancement occurred in 2006 when Echavarren's group introduced Au(I)–NHC catalysts for enyne cycloisomerization.53


image file: d5ra05920h-f1.tif
Fig. 1 Key advancements in enyne cycloisomerization using diverse metal catalysts.

Since that seminal work, a wealth of research has explored a variety of NHC–gold complexes, resulting in significant progress in this domain. This review highlights the latest breakthroughs in the Au(NHC)-catalyzed cycloisomerization of 1,n-enynes, emphasizing insightful mechanistic pathways and enhanced catalytic efficiency.

Gold-catalyzed enyne cycloisomerization

Cyclization of 1,6-enynes

Cyclopropane and polycyclopropane frameworks. In 2006, Echavarren and co-workers reported the first and effective utilization of IMesAuCl 1 (Scheme 1), along with AgSbF6, for the intermolecular bis-cyclopropanation of 1,6-enynes with alkenes.53 In this reaction, intramolecular cyclopropanation occurs, leading to the formation of a cyclopropyl gold(I) carbene intermediate 2. This intermediate is subsequently trapped by an external alkene, resulting in the production of the bis-cyclopropyl compound 3.53
image file: d5ra05920h-s1.tif
Scheme 1 Cyclopropanation of enynes with alkenes over the NHC–Au(I)–Cl catalyst.

Subsequent studies by Chung and co-workers enabled the synthesis of tetracyclo[3.3.0.02,8.04,6]octanes 6 (Scheme 2) using IPrAuCl 4.71 These highly strained compounds were derived from the double intramolecular cyclopropanation of 1,6-enynes 5, which feature a 1,4-cyclohexadiene core, through a cyclopropyl gold(I) carbene intermediate. Optimization studies detected the important role of the solvent and the type of silver salt, particularly in enhancing control over the 6 and 7 selectivity.


image file: d5ra05920h-s2.tif
Scheme 2 Intramolecular bis-cyclopropanation, catalysed by NHC–Au(I)–Cl 4.

Echavarren and co-workers found that the NHC–gold(I) complexes (e.g. 8 or 9 in Scheme 3) catalyzed 1,6-enynes containing OR groups at the propargyl position to form a cyclopropyl gold(I) carbene intermediate, which can be trapped with alkenes to obtain cyclopropanes 10 after 1,5-OR migration.72,73


image file: d5ra05920h-s3.tif
Scheme 3 Gold(I)-catalyzed intermolecular cyclopropanation of enynes after 1,5-OR migration.
Cyclopentane and cyclopentene derivatives. In 2010, Tomioka and co-workers reported the first example of gold(I) catalysis 11, including chiral C2-symmetric NHCs, to evaluate their stereocontrolling abilities in the asymmetric cyclization of 1,6-enynes. This reaction yielded the corresponding cyclopentane derivatives (e.g. 12) in high yields (up to 95%), though with only moderate enantioselectivity (up to 59% ee) (Scheme 4).74 Importantly, the study identified structural features—such as the introduction of sterically demanding diarylmethyl substituents—that improved stereocontrol by creating a chiral environment near the metal center.
image file: d5ra05920h-s4.tif
Scheme 4 The asymmetric cyclization of 1,6-enynes, catalysed by a chiral NHC–gold(I) complex.

In 2011, Shi and co-workers reported another NHC–gold(I) complex 13, featuring a pyrrolidin-1-yl group, which has been identified as the optimal catalyst for the gold(I)-catalyzed asymmetric acetoxycyclization of 1,6-enyne. This catalyst facilitates the formation of product 14 with a yield exceeding 99% and an enantiomeric excess of 59% ee at a temperature of 0 °C (Scheme 5).58 A notable strength of this work is the systematic variation of substituents to tune the steric environments around the gold center. The finding that the sterically less hindered complex 13, bearing a pyrrolidin-1-yl group, provided excellent chemical yields (>99%) but only moderate enantioselectivity (59% ee) highlights both the promise and the challenge of this catalyst class. It underscores the persistent difficulty of translating the structural chirality of ligands into effective asymmetric induction in gold catalysis, due to the substrate's coordination site being spatially removed from the chiral axis.


image file: d5ra05920h-s5.tif
Scheme 5 Intramolecular cyclization of enyne, catalysed by NHC–Au(I)–I 13.

In 2016, Gung and his group prepared a number of C2 symmetric NHC ligands, along with their corresponding gold(I) complexes. The newly developed gold complexes were used as catalysts in the cyclization reactions of 1,6-enynes. The NHC–Au(I) complex 15 demonstrated effectiveness in producing the cycloadduct 16 with ee values of up to 75% (Scheme 6).75 The study highlighted that the steric bulk of the distal aryl ring in the ortho-biphenyl moiety of the ligand is critical for controlling enantioselectivity. Large distal aryl groups generally enhance ee, whereas bulky alkyl substituents can impede substrate access and lower selectivity. Fine-tuning the steric properties of the distal aryl group offers a promising strategy to improve face-selective coordination and overall catalyst performance across different substrates.


image file: d5ra05920h-s6.tif
Scheme 6 Cyclization reactions of 1,6-enynes, catalysed by NHC–Au(I) complex 15.

In the same year, Nakada and his group synthesized novel C2 symmetric NHC ligands along with their corresponding gold(I) complexes (17 and 18).76,77 NHC ligands feature a chiral binaphthyl backbone and an N-substituted imidazolylidene moiety bonded by an eight-membered ring. These NHC–gold(I) complexes were applied as catalysts for the cyclization of 1,6-enyne, where complex 17 exhibited limited success, yielding cycloadduct 19 with an ee of 44% (Scheme 9). Additionally, using complex 18, they successfully achieved the asymmetric cyclization of 1,6-enyne, resulting in cycloadduct 20 with an ee of 78% (Scheme 7).


image file: d5ra05920h-s7.tif
Scheme 7 C2 symmetric NHC gold(I)-catalysed cyclization of 1,6-enynes.

In 2019, Zhang and co-workers reported a chiral bifunctional NHC ligand including an imidazo[1,5-a]pyridine (ImPy) moiety.78 They explored the applicability of this newly developed ligand in a range of asymmetric gold(I)-catalyzed transformations. Among these transformations, the methoxy cyclization of 1,6-enyne was successfully carried out using NHC–Au(I) complex 21, to obtain a cycloadduct 22 with an ee of 77% and a yield of 97% (Scheme 8). Studies on gold-catalyzed alkoxycyclization showed that both the ligand's structure and chirality have a significant impact on the reaction yield and enantioselectivity. Using complex 21 with AgSbF6 gave a moderate yield (52%) and a low ee (33%). Incorporating the (aS,R)-21 complex improved both the yield and enantioselectivity (up to −73%), and the choice of chloride scavenger further influenced selectivity (−77% ee with [Ag(MeCN)2]+ BARF). For sulfonamide-substituted 1,6-enynes, the (aR,R)-21 complex provided higher yields, although enantioselectivity remained modest, emphasizing the substrate-dependent nature of the ligand performance.


image file: d5ra05920h-s8.tif
Scheme 8 Chiral bifunctional NHC gold(I)-catalysed cyclization of 1,6-enynes.

Fiksdahl and co-workers reported a series of chiral gold(I)– and gold(III)–NHC complexes (e.g. 23 and 24, respectively) derived from chiral amino alcohols. The gold(I)– and gold(III)–NHC complexes were evaluated in an alkoxycyclization test reaction (Scheme 9). The gold(I) complexes 23 exhibited the highest efficiency and selectivity, achieving good yields of the target product 25. In contrast, the gold(III) complexes 24 provided the fastest conversion but were less selective because of the competing hydration of the alkyne. Both the gold(I) and gold(III) complexes (23a and 24a), with the bulky N1-Mes group, demonstrated significantly strong catalytic activity, achieving excellent yields of the target product 25 (92–99%).79


image file: d5ra05920h-s9.tif
Scheme 9 Alkoxycyclization of 1,6-enyne, catalysed by the Au(I)/(III)–NHC complex.
Ring-expanded and enol ether products. Fensterbank and co-workers described the cycloisomerization of O-tethered 1,6-enynes, catalyzed by NHC-gold(I)–Cl 4, resulting in a small-sized ring expansion and affording 9 examples of enol ethers 26 (Scheme 10).80 The introduction of a phenyl group (R = Ph) on the terminal alkyne, combined with catalyst 4, enhanced both yield and selectivity, producing ring-expansion products in moderate to excellent yields. Substrates bearing methyl, isopropyl, or vinyl groups also furnished the expected products, whereas ester-substituted compounds resulted in product mixtures. Acetylenic–cyclopropyl substrates gave very good yields, with stereochemistry confirmed by X-ray analysis. In contrast, substitution at R′ with a methyl or prenyl group led to significantly reduced yields of the ring-expansion products.
image file: d5ra05920h-s10.tif
Scheme 10 Cycloisomerization reaction of O-tethered 1,6-enynes, catalyzed by NHC–Au(I)–Cl 4.

Shi and co-workers described the NHC–Au(I)-NTf2 27-catalyzed ring expansion process that used 1,6-enyne alkynylcyclopropyl allyl ethers 28 to synthesize tetrasubstituted methylenecyclobutanones 29 in moderate to good yields (Scheme 11). This reaction involved an intramolecular [3,3]-sigmatropic rearrangement, followed by a [1,2]-allyl shift route, facilitated by a catalytic amount of water in the presence of gold(I) catalysis. This interesting mechanism was supported by various mechanistic experiments and DFT calculations. Additionally, these methylenecyclobutanone products can be transformed into polycyclic skeleton 30 through a practical three-step synthetic procedure under gold catalysis (Scheme 11).81


image file: d5ra05920h-s11.tif
Scheme 11 Cycloisomerization reaction of 1,6-enyne alkynylcyclopropyl allyl ethers over NHC–Au(I)-NTf2 27.

In 2020, Michelet et al. utilized the cycloisomerization of O-tethered 1,6-enynes catalyzed by NHC–gold(I)–Cl 4 to efficiently synthesize 21 examples of volatile enol ethers 31 with unique olfactive characteristics (Scheme 12).82 In 2021, the same group reported that 4 demonstrated impressive activities in producing other light bicyclic enol ethers. They successfully synthesized several bicyclic adducts with yields ranging from 18% to 99%. They also evaluated the NHC–Au complexes, achieving a TOF of 300 h−1.83


image file: d5ra05920h-s12.tif
Scheme 12 Cycloisomerization reaction of O-tethered 1,6-enynes.
Bicyclic and functionalized frameworks. In 2017, Liu and co-workers reported the synthesis of 21 examples of alkenylcyclopropane derivatives (e.g. 32) from 1,6-enynes and aryl diazo ketones by the cyclization of 1,6-enynes with diazo species (Scheme 13), catalyzed by the NHC–gold(I) complex 4.84 The methodology proved broadly applicable, accommodating a variety of 1,6-enynes and diazo ketones—including trans-styryl, cycloalkyl, phenyl, alkyl, and heteroaryl substrates—yielding the desired products in good to excellent yields (56–94%), with most formed as Z/E isomer mixtures.
image file: d5ra05920h-s13.tif
Scheme 13 Reactions of diazo ketones and 1,6-enynes over NHC–Au(I)–Cl 4.

Sollogoub and co-workers were the first to synthesize gold complexes of NHC-capped β-cyclodextrin (β-ICyD) (e.g. 33). The catalytic efficacy of these newly developed gold complexes was showcased through the cycloisomerization of nitrogen-tethered 1,6-enynes to obtain bicyclic products 34 with ee up to 80% and yields up to 99% (Scheme 14A).85 In 2020, the same group reported the use of NHC-capped β-cyclodextrin (β-ICyD) as a ligand in gold-catalyzed alkoxycyclization reactions (Scheme 14B). The cyclodextrin component assisted the formation of a size-exclusive chiral cavity, which permitted only small-sized nucleophiles to enter and engage in gold(I)-catalyzed enantioselective alkoxycyclization, achieving high enantioselectivity of up to 94% ee 35. It is important to note that larger nucleophiles are unable to access the cavity, and 1,6-enyne substrates would instead undergo intramolecular 6-endo-dig cyclization in the absence of nucleophiles.86


image file: d5ra05920h-s14.tif
Scheme 14 (A) Cycloisomerization of nitrogen-tethered 1,6-enynes. (B) Enantioselective alkoxycyclization catalysed by (β-ICyD)–NHC–Au(I)–Cl.

Sollogoub and co-workers, in a recent study, introduced a new class of cyclodextrin-based NHC–gold(I) catalysts for the enantioselective cycloisomerization of 1,6-enynes. The study featured three α-cyclodextrin-capped NHC–Au(I) complexes: the perbenzylated (α-ICyDBn)AuCl 36a; the permethylated (α-ICyDMe)AuCl 36b; and a mixed-substitution variant, (α-ICyDBn,Me)AuCl 36c (Scheme 15). These ligands were designed to modulate the steric and electronic environment around the metal center by exploiting the structural versatility of cyclodextrin scaffolds. Among the tested complexes, the mixed-substitution complex 36c displayed superior catalytic performance in terms of both activity and enantioselectivity. The authors attribute this enhanced performance to a well-calibrated balance between steric hindrance and cavity flexibility conferred by the mixed substituents. This structural feature is proposed to create a more favorable chiral environment around the catalytic site, leading to improved asymmetric induction. Indeed, complex 36c achieved enantioselectivities of up to 86% ee, significantly outperforming both the perbenzylated 36a and permethylated 36b analogues, as well as the commonly employed (IPr)AuCl standard catalyst.87


image file: d5ra05920h-s15.tif
Scheme 15 (α-ICyD)-NHC–gold-catalyzed enantioselective cycloisomerization of enynes.

In 2022, César and co-workers reported the preparation of the first chiral helicene-NHC gold(I) complexes (e.g. 37) that are effective in enantioselective catalysis. They demonstrated the stereoinducing potential of these enantiopure helical NHC-gold precatalysts in the benchmark Au(I)-catalyzed cycloisomerization of N-tethered 1,6-enynes to obtain corresponding bicycle compounds (e.g. 38) in moderate to good yields (Scheme 16).88 Under optimized conditions, a series of para-substituted 1,6-enynes underwent smooth cycloisomerization to give bicycles 38 with consistently high enantiomeric ratios (93:7–94.5[thin space (1/6-em)]:[thin space (1/6-em)]4.5), independent of the electronic nature of the substituents. Slight yield erosion was observed with electron-withdrawing groups, while bulky substituents such as naphthyl were compatible, providing the desired product in 67% yield with 94[thin space (1/6-em)]:[thin space (1/6-em)]6 er. Overall, this system demonstrated remarkable versatility and efficiency, outperforming earlier Au(I)-based catalytic systems in terms of consistency and substrate scope.


image file: d5ra05920h-s16.tif
Scheme 16 Cycloisomerization reaction of N-tethered 1,6-enynes.

In 2022, Zhao and co-workers reported a NHC-gold(I)-catalyzed cyclization/hydroboration of 1,6-enynes that yielded bicyclo[3.1.0]hexane boranes in moderate to good yields under mild conditions (Scheme 17). This method involves the formation of an exo-cyclopropyl gold carbene 40 through the gold-mediated 5-exo-dig cyclization of 1,6-enynes. The generated carbene then inserts into the B–H bond of Lewis base-borane adducts via transition state 41, resulting in the desired product 39 and the regeneration of the gold catalyst (Scheme 17).89 This strategy provides an efficient, one-step route to boryl-substituted bicyclo[3.1.0]hexanes with a broad substrate scope, high functional group tolerance, and products that are both air-stable and easily purified by chromatography. In addition, the method is amenable to scale-up, and the resulting borane products can be readily diversified, underscoring its strong potential in synthetic chemistry.


image file: d5ra05920h-s17.tif
Scheme 17 NHC–gold(I)-catalyzed cyclization/hydroboration of 1,6-enynes.

In 2023, Zhao and co-workers published findings on a gold-catalyzed Si–H bond insertion reaction involving 1,6-enynes and hydrosilanes (Scheme 18).90 This process utilizes cyclopropyl gold carbene intermediates, enabling the straightforward, practical, and atom-economical one-step synthesis of diverse bicyclo[3.1.0]hexane silanes, e.g. 42, achieving moderate to excellent yields of up to 91% under mild conditions. The proposed mechanism begins with the gold catalyst coordinating to the alkyne unit of 1,6-enynes to form intermediate 43. This intermediate then undergoes a 5-exo-dig cyclization, yielding the exo-cyclopropyl gold carbene species 44. Ultimately, this gold carbene inserts into the electron-rich Si–H bond of hydrosilanes, producing the desired bicyclo[3.1.0]hexane silanes 42 and regenerating the gold catalyst (Scheme 18). The method also enables the first example of gold-catalyzed carbene insertion into Ge–H bonds, efficiently affording bicyclo[3.1.0]hexane germanes and further expanding the reaction's synthetic utility.


image file: d5ra05920h-s18.tif
Scheme 18 NHC–gold-catalyzed Si–H bond insertion of carbenes from 1,6-enynes.

Blanc and co-workers recently demonstrated that NHC–Au(I) complexes (e.g. 46) exhibit catalytic activity in the cycloisomerization of a 1,6-enyne 45 in the presence of a silver salt as an activator (Scheme 19).91 The study revealed that the stereoselectivity of the reaction is significantly influenced by the structural constraints within the ligand framework. The authors showed that the highest enantioselectivity (45a, 72% ee) was obtained when using a benzimidazolin-2-ylidene derivative bearing an (S)-9-(2-hydroxy-1-phenylethyl)fluoren-9-yl N-substituent (46). The key factors contributing to this selectivity include the restricted rotation around the N–Cfluorenyl bond due to steric hindrance from the bulky NHC plane and the presence of a chiral center at the α-position of the fluorenyl ring. These structural elements play a crucial role in influencing the chiral environment of the catalytic system. The authors suggest that the choice of the silver counterion had a profound impact on the catalytic outcome. Among various silver salts tested, AgOTf provided the best stereoselectivity, likely due to its ability to stabilize the active cationic gold(I) species. The anion (OTf) is proposed to interact via hydrogen bonding with the hydroxyl group on the NHC ligand, thereby rigidifying the catalyst structure and promoting efficient chirality transfer. This unique mode of activation represents an important development in NHC-gold(I) catalysis, paving the way for further exploration of enantioselective cycloisomerization strategies.


image file: d5ra05920h-s19.tif
Scheme 19 Scope of 1,6-enyne cycloisomerization, catalyzed by the NHC–Au(I) complex 46.
Cyclization of 1,5-enynes. In 2011, Echavarren et al. reported that the intermediates in the gold-catalyzed cycloisomerization of 1,5-enynes can exhibit either carbene or carbocationic characteristics. The gold carbenes generated during the cyclization of 1,5-enynes can be trapped by external C-nucleophiles and by pendant alkenes.54,55,92,93 The intermediate cyclopropyl gold carbenes (49a or 49b) generated during this cyclization were successfully trapped, resulting in the formation of biscyclopropane derivatives (47 and 48) through a concerted reaction (Scheme 20).93 They showed, through DFT calculations, that the intramolecular cyclopropanation of 1,5-enynes occurs through a concerted reaction similar to the intra- and intermolecular cyclopropanations observed in reactions involving 1,6-enynes (Scheme 1).
image file: d5ra05920h-s20.tif
Scheme 20 Cycloisomerization of 1,5-enynes, catalyzed by Au(I)–NHC complexes.

In 2016, Shi and co-workers investigated the NHC–Au(I)-NTf2 complex 27, which effectively catalyzed the cycloisomerization of readily available 1,5-enynes, including a cyclopropane ring, yielding tricyclic cyclobutene derivatives (e.g. 50) in moderate to good yields (Scheme 21).94 The substrate scope was further evaluated, showing that when the aryl substituent was a naphthyl, pyrene, or anthracene unit, the corresponding products 50 were obtained in 43–75% yields. Mechanistic investigations, including deuterium-labeling, trapping experiments, and DFT calculations, established that the tricyclic cyclobutene functions as the key branching intermediate in divergent reaction pathways. Although the method provides efficient access to structurally diverse frameworks, the substrate scope remains largely aryl-based, and the yields are influenced by steric effects. Importantly, enantioselective variants were not explored, highlighting opportunities for the development of chiral gold catalysts. Overall, this work represents an important mechanistic advance and lays the groundwork for expanding the synthetic utility of Au(I)-catalyzed enyne cycloisomerizations.


image file: d5ra05920h-s21.tif
Scheme 21 Cycloisomerization of 1,5-enynes, catalyzed by the NHC–Au(I)-NTf2 complex 27.

Fairlamb and co-workers investigated the cycloisomerization of 1,5-enynes to test the catalytic activity of the NHC–AuBr2(N-imidate) complexes (e.g. 51, Scheme 22).95 The Au(III) imidate complexes demonstrated effective catalytic activity for the cycloisomerization, with the imidate ligand playing a key role in enhancing catalytic activity. Complex 51 achieved a high conversion of 52 (99%) (Scheme 22), making it significantly more efficient than the other complexes tested.56,57,95


image file: d5ra05920h-s22.tif
Scheme 22 1,5-Enyne cycloisomerization reaction, catalysed by NHC–AuBr2(N-imidate) complexes.

In 2017, Toste and his colleagues used square-planar chiral NHC-biphenyl-Au(III) catalysts to effectively catalyze an enantioconvergent kinetic resolution of 1,5-enynes. This process afforded bicyclo[3.1.0]-hexenes with enantioselectivities of up to 90% ee, representing the first highly enantioselective transformation achieved using the Au(III)–NHC catalyst (Scheme 23).96,97 In a related study, the same group designed an achiral Au(III)–NHC complex 54, which was integrated into a rigid metal–organic framework to geometrically inhibit unwanted decomposition by the reductive elimination of biphenylene.98 This complex exhibited catalytic activity, after chloride abstraction by TlPF6, in the cycloisomerization of 1,5-enyne.99


image file: d5ra05920h-s23.tif
Scheme 23 Cycloisomerization of 1,5-enynes, catalyzed by Au(III)–NHC complexes.

In 2024, Fensterbank and co-workers showed that cavity-driven catalysis with the β-cyclodextrin–NHC–Au(I) complex 33 offers a valuable approach for achieving highly enantioconvergent cycloisomerizations of 1,5-enynes.100 Interestingly, a remarkable enantioselectivity of 94% was obtained for one of the derivatives of 56 at 0 °C (Scheme 24). The confined catalytic cavity offers a smart design solution, enabling the catalyst to overcome substrate-controlled chirality transfer—a long-standing key challenge in gold catalysis. With enantioselectivities reaching up to 94% ee alongside high yields, this approach sets a new benchmark relative to the results achieved with earlier Au(I)- and Pt(II)-based systems. Furthermore, the work underscores the potential of host–guest interactions in supramolecular catalysts as a powerful tool for addressing demanding stereocontrol problems.


image file: d5ra05920h-s24.tif
Scheme 24 Enantioconvergent cycloisomerizations of 1,5-enynes over β-cyclodextrin–NHC–Au(I) complex 33.

In 2023, Echavarren and co-workers developed two distinct classes of cyclizations utilizing a chiral auxiliary approach with NHC–gold(I) complexes (58 and 59) as catalysts (Scheme 25). The first involved the NHC–gold(I)-catalyzed cascade cyclization of 1,5-enynes to obtain spirocyclic compounds (e.g. 60) in high yields. Additionally, they reported NHC–gold(I)-catalyzed alkoxycyclization of 1,6-enynes to obtain the 6-endo-dig products (e.g. 61).101


image file: d5ra05920h-s25.tif
Scheme 25 Cycloisomerization of 1,5-enynes and 1,6-enynes, catalyzed by Au(III)–NHC complexes.
Cyclization of 1,7-enynes. In 2011, Kumar and Waldmann reported a novel 8-endo-dig cyclization of 1,7-enynes, catalyzed by an NHC–gold(I) complex 4. They noted the formation of cyclopropyl-fused compounds 66 in very low yields during the 8-endo-dig cyclization of 1,7-enynes 62 (Scheme 26).102 This process involved the coordination of gold(I) to the alkyne, facilitating cyclization and leading to the formation of cationic intermediate 64. The cationic intermediate was stabilized by the electron-donating effect of the ether oxygen atom, which also promoted the cyclization. Cation 64 either collapsed to form benzoxocine 63 or generated a cyclopropane-substituted gold intermediate 65, which, upon protodeauration, yielded cyclopropyl-fused compounds 66 (Scheme 26). Overall, this gold(I)-catalyzed 8-endo-dig cyclization provides a valuable solution to the long-standing synthetic challenge of constructing benzoxocines, a scaffold central to many biologically active natural products. While the method demonstrates impressive scope and efficiency, key considerations remain regarding stereocontrol, scalability, and compatibility with sensitive functional groups, which will determine its broader applicability. Moving forward, the development of enantioselective variants, integration into cascade or one-pot strategies, and application in total syntheses could make this transformation a powerful tool in medicinal chemistry and natural product discovery.
image file: d5ra05920h-s26.tif
Scheme 26 Formation of benzoxocines 63 and cyclopropyl-fused compounds 66, catalyzed by the NHC–Au(I) complex.

In 2019, Shi and co-workers reported the NHC-gold(I)-catalyzed cascade cyclization of O-tethered 1,7-enynes containing a cyclopropane moiety 68, to obtain highly substituted furans 69 in good yields (Scheme 27).103 The proposed mechanism included an intramolecular O-nucleophilic attack, followed by a tandem cyclization reaction and a 3,3-sigmatropic rearrangement of the allyl group to produce intermediate 70. Subsequently, a C–C bond cleavage of the cyclopropane moiety, driven by aromatization in the presence of a cationic gold catalyst, along with further reactions with electrophiles, led to the final products 69 (Scheme 27, route a). Interestingly, for substrates 68 with a methyl or phenyl group at the R′′′ position, the reaction followed a completely different pathway: the reaction was catalysed by 67 to yield 4-oxaspiro-[bicyclo[4.2.0]octane-2,10-cyclopropan]-1(8)-enes 71 in moderate yields. The substituent on the alkenyl moiety increased its electron density, thereby inhibiting the O-nucleophilic attack. As a result, the NHC–gold(I)-catalyzed 1,7-enyne cyclization proceeded to obtain a gold carbenoid intermediate 72, which then underwent ring expansion to yield the corresponding compound 71 (Scheme 27, route b).


image file: d5ra05920h-s27.tif
Scheme 27 NHC-gold(I)-catalyzed cascade cyclization of O-tethered 1,7-enynes.
Cyclization of 1,4-enynes. Chan and co-workers explored NHC–gold(I) complex 27-catalysed 1,4-enyne acetate cycloisomerization, followed by oxidation by DDQ, to provide a diverse array of 1H-indene products, e.g. 74, containing various substitution patterns. The yields from the corresponding substrates ranged from 22% to 92% (Scheme 28).104 The proposed mechanism included the activation of the 1,4-enyne motif 73 in the substrate by the gold(I) catalyst, leading to the formation of a gold(I)-coordinated species (Scheme 28). This resulted in a [2,3]-sigmatropic rearrangement of the acetate functional group, producing the cyclopentenium intermediate 75, which could then afford the 1,3-cyclopentadiene adduct. Further activation of the remaining alkyne group in this adduct by the gold(I) complex could initiate a 6-endo-dig cyclization of the resulting organogold species 76. This process involved the attack of the five-membered carbocycle on the gold-coordinated alkyne motif, affording the bicyclic cation 77. The subsequent deauration of this cation generated two isomers of dihydro-1H-indene under acidic reaction conditions. In the presence of DDQ, the subsequent oxidation of either or a mixture of both isomers produced the aromatic carbocycle 74 (Scheme 28).104
image file: d5ra05920h-s28.tif
Scheme 28 Cycloisomerization reaction of 1,4-enyne acetates, catalysed by 27.

In 2020, the same group reported the NHC–gold(I) complex 27- and Brønsted acid-catalysed cycloisomerization of 2- and 3-indolyl tethered 1,4-enyne acetate (e.g. 78 and 80) to obtain spiro[4,n]alkyl[b]indoles (n = 4–6), such as 79 and 81, under room temperature conditions and in open air (Scheme 29).105 A broad range of 2-indolyl tethered enyne acetates was examined, affording indolyl-fused spirocyclic derivatives in moderate to excellent yields (48–91%). The method displayed wide functional group tolerance, accommodating aryl, heteroaryl, and alkyl substituents—including n-butyl and cyclohexyl—at the alkynyl position. Substrates bearing electron-donating or electron-withdrawing substituents on the indole ring also underwent smooth cyclization, while variations in N-protecting groups and tether lengths furnished diverse spirocyclic frameworks. Together, these results highlight the robustness, versatility, and generality of this catalytic protocol.


image file: d5ra05920h-s29.tif
Scheme 29 Spirocyclization of 1,4-enyne, catalysed by 27 and Brønsted acid.
Other enynes. In 2016, Echavarren and co-workers studied the diastereoselective cyclization of (R)-82 to form the 9-membered ring 83 using 5 mol% of catalyst 59, resulting in a 9[thin space (1/6-em)]:[thin space (1/6-em)]1 diastereomeric ratio and a 75% yield (Scheme 30).106 Among the catalysts examined, complex 59 proved to be the most effective, offering superior yield and selectivity. By contrast, gold(I) phosphine complexes provided only moderate yields and lower diastereoselectivity, and they suffered from side reactions, such as alkyne hydration. The excellent outcome with complex 59 highlights the critical role of the IPr ligand and BAr4F counterion in stabilizing the catalytic system and enabling this transformation with much greater efficiency than those provided by the other complexes tested.
image file: d5ra05920h-s30.tif
Scheme 30 NHC–gold(I)-catalyzed [2 + 2] cycloaddition of 1,10-enynes.

Chen and co-workers reported the first example of NHC–gold(I) complex 1 catalyzing a formal intermolecular [4 + 2 + 1] cycloaddition using 1,3-dien-8-yne 84 and diazoester 85 (Scheme 31). This approach provides a straightforward method to access a range of structurally complicated [5.3.0] bicyclic adducts, e.g. 86, achieving moderate to high diastereoselectivities. The proposed mechanism highlights the nucleophilic addition of 85 to the cyclopropyl gold carbene intermediate as a crucial step for establishing the quaternary chiral carbon center. This is followed by a Cope rearrangement of the resulting divinyl cyclopropane 87, leading to the desired [5.3.0] bicyclic compounds 86 (Scheme 31).107


image file: d5ra05920h-s31.tif
Scheme 31 NHC–gold(I)-catalysed [4 + 2 + 1] cycloaddition of 1,3-dien-8-yne with different diazo esters.
Oxidative cyclization of enynes. In 2007, Toste et al. introduced an interesting method for the NHC gold-catalyzed oxidative transformations of alkynes, utilizing sulfoxides as oxidants to produce a range of cyclopropyl aldehydes in high yields.108 Notably, the carbene nature of the intermediates was confirmed through the transfer of oxygen atoms from a sulfoxide to a cationic gold(I) species. The reaction of 1,6-enynes with two equivalents of diphenylsulfoxide resulted in the successful synthesis of various cyclopropyl aldehydes 88, with isolated yields ranging from 90% to 94% and a broad substrate scope. This transformation was achieved using IPrAuCl 4/AgSbF6 (2.5–5 mol%) as the catalyst (Scheme 32).
image file: d5ra05920h-s32.tif
Scheme 32 Synthesis of cyclopropyl aldehydes, catalysed by NHC–Au(I)–Cl 4.

In the same year, Gagosz et al. reported a range of NHC–Au(I)-NTf2 complexes that have been identified as effective catalysts for various cycloisomerization reactions with enynes.109 The results achieved with NHC–Au(I)-NTf2 complexes were similar to those obtained with the (NHC–Au(I)–Cl/AgSbF6) catalytic system reported by the groups of Toste and Echavarren.

In 2011, Shi and co-workers identified the NHC–gold(I) catalyst 89 as the most effective catalyst for the asymmetric oxidative rearrangement of 1,6-enynes.58 This catalyst produced the corresponding aldehydes 90 in high yields, exceeding 99%, and demonstrated moderate enantioselectivities ranging from 3.1% to 70% ee when PhCl was used as the solvent at a temperature of 10 °C (Scheme 33). Further optimization identified Ph2SO as the optimal oxidant, with the best results achieved under 89/AgSbF6 catalysis in anhydrous PhCl at 10 °C in the presence of 4 Å molecular sieves. Under these conditions, aryl-substituted enynes provided products in excellent yields (>99%) with moderate enantioselectivities (58–64% ee). Sulfonyl-substituted enynes displayed more variable outcomes, giving up to 70% ee with 4-bromobenzenesulfonyl but very low enantioselectivities (<11% ee) with bulky or electron-rich substituents. Oxygen-tethered enynes also delivered high yields but poor ee, while enynes bearing terminal alkenyl or nonterminal alkynyl groups reacted sluggishly, affording low yields. Overall, these findings demonstrate that while the method is highly efficient in yield, the enantioselectivity is strongly dependent on the steric and electronic nature of the substrate.


image file: d5ra05920h-s33.tif
Scheme 33 Synthesis of cyclopropyl aldehydes, catalysed by NHC–Au(I)–I 89.

In the same year, Qian and Zhang reported a process that involves the cyclization of amide-tethered 1,7-enynes using an NHC–gold(I) catalytic system (4/AgNTf2) and 8-methylquinoline oxide as an oxidant to prepare the [4.1.0] bicyclic compound 91a (Scheme 34). Additionally, they used the same gold-catalyzed oxidative cyclization of amide- or ketone-tethered 1,6-enynes to produce hetero- and carbo[3.1.0] bicyclic ketones 91.110 Importantly, 8-methylquinoline N-oxide proved to be a particularly effective external oxidant, offering mild, acid-free conditions; high reaction rates; and room temperature operation. Under these conditions, yields were improved, as demonstrated by product 91c, whose yield increased from 46% to 53%. The system also showed broad substrate tolerance: both the aryl and alkyl substituents on the alkyne and a range of N-protecting groups (benzyl, sulfonyl, methyl) were well accommodated. Substitution at the alkene moiety was also successful—methallyl derivative gave bicyclo[3.1.0]hexan-2-one in a 60% yield with two adjacent quaternary centers, while a benzyl-substituted derivative afforded the product as a mixture of diastereomers. Furthermore, [4.1.0] bicyclic product 91a was obtained in moderate yield, demonstrating the versatility and synthetic potential of this transformation (Scheme 34).


image file: d5ra05920h-s34.tif
Scheme 34 Gold(I)-catalyzed oxidative-cyclopropanation of 1,6-enynes and 1,7-enynes using quinoline N-oxides.

In 2011, Liu and co-workers reported the oxidative cyclization of 1,5-enynes, suggesting the formation of α-oxo gold carbenes as intermediates. The 1,5-enynes featuring aromatic or alkenyl linkers yielded cyclopropyl ketones 92 in good yields over a gold 4-catalyzed reaction, with 8-methylquinoline N-oxide as the oxidant. Most reactions required only a 5 mol% catalyst loading and short reaction times, although slightly more stringent conditions were necessary for a substrate with an internal alkyne and for a 1,6-enyne to produce 92a (Scheme 35).111 To evaluate the scope, a wide variety of 1,5-enynes was explored. The methodology proved highly versatile, converting vinyl-, alkyl-, aryl-, and cyclopropyl-substituted enynes into the corresponding indanones in moderate to high yields (53–89%). Trisubstituted alkenes and nonbenzenoid enynes also cyclized efficiently, affording indanone and cyclopentenone derivatives in 61–84% yields (e.g. 92c). Furthermore, phenyl-substituted enynes with chloro or methoxy groups provided products in 67–76% yields (e.g. 92b), highlighting the broad substrate scope, functional group tolerance, and generality of this oxidative cyclization.


image file: d5ra05920h-s35.tif
Scheme 35 Gold(I)-catalyzed oxidative cyclization of 1,5-enynes and 1,6-enynes.

In 2014, Bielawski et al. reported a series of NHCs as ligands in gold(I)-catalyzed 1,6-enyne cycloisomerization reactions to investigate the impacts of ligand steric and electronic effects on the resulting product mixtures.60 The results obtained with the NHC–Au(I)–Cl complexes were similar to those achieved with the (NHC–Au(I)–Cl/AgSbF6) catalytic system reported by Shi's group. Nevertheless, their results showed that the major product in the NHC–gold(I)-catalyzed 1,6-enyne cycloisomerization reactions was the fused bicyclic products (e.g. 88).

In 2015, Echavarren and colleagues reported the gold(I)-catalyzed oxidative cyclization of enantioenriched 1,5-enynes 93 using 3,5-dichloropyridine N-oxide as the oxidant. This reaction produced the desired product 94 in good yield (74%), along with 15% of the cycloisomerized product 95. The final step involved allylic oxidation, which enabled the high-yield total synthesis of (–)-nardoaristolone B 96 (93%) (Scheme 36).112 Earlier studies using 27 with 8-methylquinoline N-oxide had delivered only modest results, giving 20% of the oxidative cyclization product and 25% of the cycloisomerization product. Careful optimization revealed the crucial role of the oxidant: 3,5-dichloropyridine N-oxide proved optimal, while its isomer 2,6-dichloropyridine N-oxide exclusively afforded the diene 95 in a 55% yield. The formation of both oxidative and cycloisomerization products suggests a common cyclopropyl gold(I) intermediate, although an alternative pathway involving early oxidation to an α-oxo gold carbine followed by intramolecular cyclopropanation cannot be excluded.


image file: d5ra05920h-s36.tif
Scheme 36 Gold(I)-catalyzed oxidative cyclization of 1,5-enyne in the synthesis of (–)-nardoaristolone B.

In 2013, Li and co-workers reported the gold-catalyzed oxidative cyclopropanation of N-allylynamide using 1/AgBF4 as the catalyst and pyridine N-oxide as the oxidant, yielding various 3-aza-bicyclo[3.1.0]-hexan-2-one derivatives, e.g. 97, in moderate to excellent yields (Scheme 37).113 The reaction showed a broad substrate scope, tolerating various protecting groups (Ms, Ns, 2-trimethylsilylethanesulfonyl (SES), p-MeOC5H4SO2, p-BrC6H4SO2) and enabling further synthetic flexibility. Both terminal and substituted alkynes proved suitable: the terminal alkyne gave an 85% yield, while the TMS-substituted analogue delivered a 90% yield after desilylation. Halogen substituents (Br, F) and carbonyl-substituted derivatives were also efficiently converted. Substrates with differently substituted allyl units yielded products with vicinal quaternary centers in high yield, though steric hindrance in some cases led to 1,2-dicarbonyl by-products. Electron-rich aryl alkynes similarly favored dicarbonyl formation, highlighting the influence of electronic effects. Notably, reactions with phenyl- or methyl-substituted alkenes yielded exclusively the trans-isomer, demonstrating excellent stereoselectivity.


image file: d5ra05920h-s37.tif
Scheme 37 Gold-catalyzed oxidative cyclopropanation of N-allyl ynamides.

In the same year, Liu and colleagues reported the efficient synthesis of cyclopropyl-indanimines 99 by treating 1,5-enynes with N-iminopyridinium ylide (1.2 equiv.) in heated 1,2-dichloroethane (DCE, 80 °C), in the presence of catalyst 27 (5 mol%). The resulting imine products, e.g., 99, were obtained in yields ranging from 30% to 87% (Scheme 38).114 Notably, a gold carbene intermediate 98 was proposed as the key intermediate, based on prior studies on the oxidative cyclopropanation of 1,5-enynes.111 Substrates bearing cyclopentylidene and cyclohexylidene groups gave high yields (85–87%), while stereospecific transformations of regioisomeric enynes supported a gold carbene intermediate. Halogen-substituted enynes (Cl, F) furnished products in 68–77% yields, though electron-rich substrates, such as methoxy derivatives, were less efficient, with one example affording only a 30% yield and another failing due to insufficient alkyne activation.


image file: d5ra05920h-s38.tif
Scheme 38 NHC–Au(I)-catalyzed iminocyclization of various 1,5-enynes.

Echavarren and coworkers demonstrated the efficient synthesis of 17 examples of 1-substituted barbaralones 100 through gold(I) 58-catalyzed oxidative cyclization of 7-(substituted ethynyl)-1,3,5-cycloheptatrienes (Scheme 39).115 This method enables the shortest synthesis of bullvalene and its derivatives, with the parent bullvalene 101 obtained in five steps from commercially available starting materials, achieving a 10% overall yield. This represents a significant improvement over previous methods, which required nine or more steps with lower efficiency. The straightforward access to barbaralones facilitates the construction of complex cage systems with novel molecular architectures.115,116


image file: d5ra05920h-s39.tif
Scheme 39 NHC–Au(I)-catalyzed oxidative reaction of 7-ethynyl-1,3,5-cycloheptatrienes to form 1-substituted barbaralone.

In 2016, Shi and coworkers used a NHC-gold(I)-catalyzed method for converting aryl propargyl ethers into 2H-chromene derivatives 102 through intramolecular hydroarylation with high efficiency. Additionally, it has been demonstrated that 2H-chromene derivatives 102 containing a methylenecyclopropane moiety can undergo further transformation into cyclobutenes via ring enlargement under gold(I) catalysis using 58 (Scheme 40). This provides an alternative and effective approach for cyclobutene synthesis.117 The substrate scope demonstrated good generality: aryl propargyl ethers bearing methyl or halogen substituents (F, Cl, Br) on the benzene ring afforded cyclobutenes in moderate yields (41–64%). The substituent effects were clear—para-methyl groups increased the electron density at C3, enhancing hydroarylation and giving higher yields than meta-methyl analogues, while para-chloro groups lowered the electron density and reduced the yields compared to their meta-substituted counterparts. A phenyl substituent at the terminal alkyne provided cyclobutene in good yield (76%). In contrast, substrates bearing strongly electron-withdrawing (m-NO2) or electron-donating (p-MeO) groups, as well as those with ester substituents (R′ = CO2Et), afforded complex mixtures, likely due to unfavorable electronic effects.


image file: d5ra05920h-s40.tif
Scheme 40 Conversion of aryl propargyl ethers into 2H-chromene derivatives via 58.

In 2018, the same group reported NHC–gold-catalyzed annulations of aniline-linked 1,7-enynes containing a methylenecyclopropane, yielding 1,2-dihydroquinoline derivatives 103 in moderate yields under mild conditions (Scheme 41). The formation of 1,2-dihydroquinolines bearing a cyclobutene moiety may proceed through a cyclopropyl gold–carbene intermediate formed twice during the process.118 Substrates bearing electron-withdrawing halogens on both aromatic rings afforded hydroquinoline products in 51–63% total yields, while alkyl- and naphthyl-substituted derivatives provided the product in 41–66% yields. A meta-methoxy substituent gave a moderate yield (61%), whereas ortho- and para-methoxy groups led only to complex mixtures, highlighting the strong positional effect of electron-rich substituents. Similarly, heteroaryl substrates (furan and thiophene) in this reaction gave only complex mixtures, and no reaction was observed under the standard conditions. In all successful cases, the hydroquinoline products 103 were consistently obtained as the major products.


image file: d5ra05920h-s41.tif
Scheme 41 NHC-gold-catalyzed intramolecular annulation of aniline-linked 1,7-enynes.

In 2024, Chen and co-workers synthesized cyclopentenyl compounds by employing a NHC-gold-catalyzed reaction of 1,3-enynes with various olefins in the presence of pyridine N-oxide as the oxidant. Notably, when reacting 1,3-enynes with aryl olefins, they successfully produced a range of cyclopentenyl ketone derivatives (e.g. 108) through a formal [3 + 2] cycloaddition (Scheme 42).119 The authors proposed a reaction mechanism, which is depicted in (Scheme 42). Initially, the gold-containing N-dienoxypyridinium intermediate 106 is formed in situ by the addition of an N-oxide to the gold-activated 1,3-enyne 104. This process generates the vinyl-gold carbocation intermediate 107, formed from the 105 reaction, whose stability is enhanced by the neighboring phenyl group. The stabilized carbocation undergoes intramolecular cyclization through an interaction with the vinyl–gold bond, ultimately producing the formal [3 + 2] cycloadduct 108.


image file: d5ra05920h-s42.tif
Scheme 42 NHC–gold-catalyzed [3 + 2] cycloaddition of 1,3-enyne with different aryl olefins.

Conclusions

The field of Au(NHC)-catalyzed cycloisomerization of enynes has witnessed remarkable growth, driven by the unique properties of NHC ligands and the exceptional reactivity of gold complexes. As demonstrated across a variety of systems—including 1,6-enynes, 1,5-enynes, other 1,n-enynes, and oxidative cyclization pathways—these transformations offer powerful, atom-economical routes to structurally diverse and complex cyclic frameworks. Mechanistic studies continue to reveal the critical roles of ligand design, electronic effects, and substrate architecture in dictating selectivity and efficiency. Moving forward, the integration of computational modeling, expanded ligand libraries, and green oxidative systems will likely further enhance the scope and sustainability of these catalytic processes. Collectively, NHC–Au complexes are poised to remain at the forefront of enyne cycloisomerization, offering robust tools for both academic research and industrial innovation.

Conflicts of interest

There are no conflicts to declare.

Data availability

No primary research results, software, or code have been included, and no new data were generated or analyzed as part of this review.

Acknowledgements

We sincerely appreciate the Ministry of Higher Education and Scientific Research in Iraq for supporting this work.

References

  1. K. Öfele, J. Organomet. Chem., 1968, 12, 42–43 CrossRef.
  2. H. W. Wanzlick and H. J. Schönherr, Angew. Chem., Int. Ed., 1968, 7, 141–142 CrossRef CAS.
  3. C. Romain, S. Bellemin-Laponnaz and S. Dagorne, Coord. Chem. Rev., 2020, 422, 213411 CrossRef.
  4. S. J. Hock, L.-A. Schaper, W. A. Herrmann and F. E. Kühn, Chem. Soc. Rev., 2013, 42, 5073–5089 RSC.
  5. T. Scattolin and S. P. Nolan, Trends in Chemistry, 2020, 2, 721–736 CrossRef.
  6. L. A. Schaper, S. J. Hock, W. A. Herrmann and F. E. Kuehn, Angew. Chem., Int. Ed., 2013, 52, 270–289 CrossRef PubMed.
  7. H. D. Velazquez and F. Verpoort, Chem. Soc. Rev., 2012, 41, 7032–7060 RSC.
  8. D. Zhang and G. Zi, Chem. Soc. Rev., 2015, 44, 1898–1921 RSC.
  9. P. Gao and M. Szostak, Coord. Chem. Rev., 2023, 485, 215110 CrossRef.
  10. A. Jayaraj, A. V. Raveedran, A. T. Latha, D. Priyadarshini and P. C. A. Swamy, Coord. Chem. Rev., 2023, 478, 214922 CrossRef.
  11. A. H. Mageed, J. Organomet. Chem., 2019, 902, 120965 CrossRef.
  12. M. K. Pandey and J. Choudhury, ACS Omega, 2020, 5, 30775–30786 CrossRef.
  13. A. Doddi, M. Peters and M. Tamm, Chem. Rev., 2019, 119, 6994–7112 CrossRef.
  14. V. Nesterov, D. Reiter, P. Bag, P. Frisch, R. Holzner, A. Porzelt and S. Inoue, Chem. Rev., 2018, 118, 9678–9842 CrossRef.
  15. A. H. Mageed, B. W. Skelton, A. N. Sobolev and M. V. Baker, Tetrahedron, 2018, 74, 2956–2966 CrossRef.
  16. S. Diez-Gonzalez, N. Marion and S. P. Nolan, Chem. Rev., 2009, 109, 3612–3676 CrossRef PubMed.
  17. T. Zhou, G. Utecht-Jarzyńska and M. Szostak, Coord. Chem. Rev., 2024, 512, 215867 CrossRef.
  18. A. D'Amato, M. Sirignano, S. Russo, R. Troiano, A. Mariconda and P. Longo, Catalysts, 2023, 13, 811 CrossRef.
  19. A. H. Mageed and K. Al-Ameed, RSC Adv., 2023, 13, 17282–17296 RSC.
  20. P. Bellotti, M. Koy, M. N. Hopkinson and F. Glorius, Nat. Rev. Chem., 2021, 5, 711–725 CrossRef CAS PubMed.
  21. H. M. Lee, C.-C. Lee and P.-Y. Cheng, Curr. Org. Chem., 2007, 11, 1491–1524 CrossRef CAS.
  22. M. Poyatos, J. A. Mata and E. Peris, Chem. Rev., 2009, 109, 3677–3707 CrossRef CAS.
  23. M. N. Hopkinson, C. Richter, M. Schedler and F. Glorius, Nature, 2014, 510, 485–496 CrossRef CAS PubMed.
  24. F. He, K. P. Zois, D. Tzeli, A. A. Danopoulos and P. Braunstein, Coord. Chem. Rev., 2024, 514, 215757 CrossRef CAS.
  25. G. R. P. Vasu, K. R. M. Venkata, R. R. Kakarla, K. V. Ranganath and T. M. Aminabhavi, Environ. Res., 2023, 225, 115515 CrossRef PubMed.
  26. Y.-F. Zhang, Y.-K. Yin, H. Zhang and Y.-F. Han, Coord. Chem. Rev., 2024, 514, 215941 CrossRef CAS.
  27. W. Zhao, V. Ferro and M. V. Baker, Coord. Chem. Rev., 2017, 339, 1–16 CrossRef CAS.
  28. A. H. Mageed and I. S. Hadi, ChemistrySelect, 2024, 9, e202304737 CrossRef CAS.
  29. M. A. Hussein and A. Hassoon Mageed, Asian J. Org. Chem., 2025, 14, e202400528 CrossRef CAS.
  30. R. P. Herrera and M. C. Gimeno, Chem. Rev., 2021, 121, 8311–8363 CrossRef CAS PubMed.
  31. A. H. Mageed, B. W. Skelton and M. V. Baker, Dalton Trans., 2017, 7844–7856 RSC.
  32. S. Engel, E.-C. Fritz and B. J. Ravoo, Chem. Soc. Rev., 2017, 46, 2057–2075 RSC.
  33. C. Eisen, J. M. Chin and M. R. Reithofer, Chem.–Asian J., 2021, 16, 3026–3037 CrossRef CAS.
  34. K. Al-Ameed and A. H. Mageed, Polyhedron, 2021, 205, 115323 CrossRef CAS.
  35. A. H. Mageed, B. W. Skelton, A. N. Sobolev and M. V. Baker, Eur. J. Inorg. Chem., 2018, 2018, 109–120 CrossRef CAS.
  36. L. Rocchigiani and M. Bochmann, Chem. Rev., 2020, 121, 8364–8451 CrossRef PubMed.
  37. R. Jouhannet, S. Dagorne, A. Blanc and P. de Frémont, Chem.–Eur. J., 2021, 27, 9218–9240 CrossRef CAS PubMed.
  38. D. Qian and J. Zhang, Chem. Soc. Rev., 2015, 44, 677–698 RSC.
  39. M. Michalak and W. Kośnik, Catalysts, 2019, 9, 890 CrossRef CAS.
  40. A. Collado, D. J. Nelson and S. P. Nolan, Chem. Rev., 2021, 121, 8559–8612 CrossRef CAS PubMed.
  41. A. Johnson and M. C. Gimeno, Organometallics, 2017, 36, 1278–1286 CrossRef.
  42. P. de Frémont, N. Marion and S. P. Nolan, J. Organomet. Chem., 2009, 694, 551–560 CrossRef.
  43. M. V. Baker, P. J. Barnard, S. J. Berners-Price, S. K. Brayshaw, J. L. Hickey, B. W. Skelton and A. H. White, J. Organomet. Chem., 2005, 690, 5625–5635 CrossRef.
  44. P. J. Barnard, M. V. Baker, S. J. Berners-Price and D. A. Day, J. Inorg. Biochem., 2004, 98, 1642–1647 CrossRef PubMed.
  45. P. J. Barnard, M. V. Baker, S. J. Berners-Price, B. W. Skelton and A. H. White, Dalton Trans., 2004, 1038–1047 RSC.
  46. M. Monticelli, M. Baron, C. Tubaro, S. Bellemin-Laponnaz, C. Graiff, G. Bottaro, L. Armelao and L. Orian, ACS Omega, 2019, 4, 4192–4205 CrossRef PubMed.
  47. P. J. Barnard, L. E. Wedlock, M. V. Baker, S. J. Berners-Price, D. A. Joyce, B. W. Skelton and J. H. Steer, Angew. Chem., Int. Ed., 2006, 45, 5966–5970 CrossRef.
  48. M. Baron, C. Tubaro, M. Basato, A. Biffis, M. M. Natile and C. Graiff, Organometallics, 2011, 30, 4607–4615 CrossRef.
  49. A. Neshat, P. Mastrorilli and A. Mousavizadeh Mobarakeh, Molecules, 2021, 27, 95 CrossRef PubMed.
  50. E. Soriano and J. Marco-Contelles, Computational Mechanisms of Au and Pt Catalyzed Reactions, 2011, 1–29 Search PubMed.
  51. A. Arcadi, Chem. Rev., 2008, 108, 3266–3325 CrossRef.
  52. D. J. Gorin, B. D. Sherry and F. D. Toste, Chem. Rev., 2008, 108, 3351–3378 CrossRef PubMed.
  53. S. López, E. Herrero-Gómez, P. Pérez-Galán, C. Nieto-Oberhuber and A. M. Echavarren, Angew. Chem., 2006, 118, 6175–6178 CrossRef.
  54. C. H. Amijs, C. Ferrer and A. M. Echavarren, Chem. Commun., 2007, 698–700 RSC.
  55. C. H. Amijs, V. Lopez-Carrillo, M. Raducan, P. Perez-Galan, C. Ferrer and A. M. Echavarren, J. Org. Chem., 2008, 73, 7721–7730 Search PubMed.
  56. J. P. Reeds, A. C. Whitwood, M. P. Healy and I. J. Fairlamb, Organometallics, 2013, 32, 3108–3120 CrossRef CAS.
  57. J. P. Reeds, M. P. Healy and I. J. Fairlamb, Catal. Sci. Technol., 2014, 4, 3524–3533 RSC.
  58. W. Wang, J. Yang, F. Wang and M. Shi, Organometallics, 2011, 30, 3859–3869 Search PubMed.
  59. R. Harris and R. Widenhoefer, Chem. Soc. Rev., 2016, 45, 4533–4551 Search PubMed.
  60. K. Arumugam, B. Varghese, J. N. Brantley, S. S. Konda, V. M. Lynch and C. W. Bielawski, Eur. J. Org Chem., 2014, 2014, 493–497 CrossRef CAS.
  61. A. s. F. León Rojas, S. H. Kyne and P. W. H. Chan, Acc. Chem. Res., 2023, 56, 1406–1420 Search PubMed.
  62. A. Mariconda, M. Sirignano, R. Troiano, S. Russo and P. Longo, Catalysts, 2022, 12, 836 Search PubMed.
  63. A. G. Nair, R. T. McBurney, M. R. Gatus, S. C. Binding and B. A. Messerle, Inorg. Chem., 2017, 56, 12067–12075 Search PubMed.
  64. S. P. Nolan, Acc. Chem. Res., 2011, 44, 91–100 CrossRef CAS PubMed.
  65. R. Dorel and A. M. Echavarren, Chem. Rev., 2015, 115, 9028–9072 CrossRef CAS.
  66. B. M. Trost, M. Lautens, M. H. Hung and C. S. Carmichael, J. Am. Chem. Soc., 1984, 106, 7641–7643 CrossRef CAS.
  67. R. Grigg, P. Stevenson and T. Worakun, Tetrahedron, 1988, 44, 4967–4972 CrossRef CAS.
  68. B. M. Trost and F. D. Toste, J. Am. Chem. Soc., 2000, 122, 714–715 Search PubMed.
  69. M. Méndez, M. P. Munoz, C. Nevado, D. J. Cardenas and A. M. Echavarren, J. Am. Chem. Soc., 2001, 123, 10511–10520 Search PubMed.
  70. C. Nieto-Oberhuber, M. Munoz-Herranz, E. Buñuel, C. Nevado, D. J. Cárdenas and A. M. Echavarren, Angew. Chem., Int. Ed., 2004, 43, 2402–2406 CAS.
  71. S. M. Kim, J. H. Park, S. Y. Choi and Y. K. Chung, Angew. Chem., 2007, 119, 6284–6287 Search PubMed.
  72. M. Gaydou, R. E. Miller, N. Delpont, J. Ceccon and A. M. Echavarren, Angew. Chem., 2013, 52, 6396–6399 CrossRef CAS.
  73. P. Calleja, Ó. Pablo, B. Ranieri, M. Gaydou, A. Pitaval, M. Moreno, M. Raducan and A. M. Echavarren, Chem. -Eur. J., 2016, 22, 13613–13618 CrossRef CAS PubMed.
  74. Y. Matsumoto, K. B. Selim, H. Nakanishi, K.-i. Yamada, Y. Yamamoto and K. Tomioka, Tetrahedron Lett., 2010, 51, 404–406 CrossRef CAS.
  75. B. W. Gung, M. R. Holmes, C. A. Jones, R. Ma and C. L. Barnes, Tetrahedron Lett., 2016, 57, 3912–3915 CrossRef CAS.
  76. K. Usui, T. Yoshida and M. Nakada, Tetrahedron: Asymmetry, 2016, 27, 107–113 CrossRef CAS.
  77. N. Okitsu, T. Yoshida, K. Usui and M. Nakada, Heterocycles, 2016, 92, 720–732 CrossRef CAS.
  78. J.-Q. Zhang, Y. Liu, X.-W. Wang and L. Zhang, Organometallics, 2019, 38, 3931–3938 CrossRef CAS PubMed.
  79. H. F. Jónsson, A. Orthaber and A. Fiksdahl, Dalton Trans., 2021, 50, 5128–5138 RSC.
  80. A. Simonneau, Y. Harrak, L. Jeanne-Julien, G. Lemiere, V. Mouriès-Mansuy, J. P. Goddard, M. Malacria and L. Fensterbank, ChemCatChem, 2013, 5, 1096–1099 CrossRef CAS.
  81. W. Zang, L. Wang, Y. Wei, M. Shi and Y. Guo, Adv. Synth. Catal., 2019, 361, 2321–2328 CAS.
  82. R. Laher, C. Marin and V. Michelet, Org. Lett., 2020, 22, 4058–4062 Search PubMed.
  83. R. Laher, E. Gentilini, C. Marin and V. Michelet, Synthesis, 2021, 53, 4020–4029 CAS.
  84. B. S. Kale, H. F. Lee and R. S. Liu, Adv. Synth. Catal., 2017, 359, 402–409 Search PubMed.
  85. P. Zhang, C. Tugny, J. M. Suárez, M. Guitet, E. Derat, N. Vanthuyne, Y. Zhang, O. Bistri, V. Mouriès-Mansuy and M. Ménand, Chem, 2017, 3, 174–191 CAS.
  86. P. Zhang, C. Tugny, J. M. Suárez, M. Guitet, E. Derat, N. Vanthuyne, Y. Zhang, O. Bistri, V. Mouriès-Mansuy, M. Ménand Tugny, N. del Rio, M. Koohgard, N. Vanthuyne, D. Lesage, K. Bijouard, P. Zhang, J. Meijide Suárez, S. Roland, O. Bistri-Aslanoff, M. Sollogoub, L. Fensterbank and V. Mouriès-Mansuy, ACS Catal., 2020, 10, 5964–5972 Search PubMed.
  87. G. Xu, O. Bistri-Aslanoff, V. Mouriès-Mansuy, L. Fensterbank, Y. Zhang, S. Roland and M. Sollogoub, Eur. J. Org Chem., 2025, e202401378 CrossRef CAS.
  88. L. Pallova, L. Abella, M. Jean, N. Vanthuyne, C. Barthes, L. Vendier, J. Autschbach, J. Crassous, S. Bastin and V. César, Chem. -Eur. J., 2022, 28, e202200166 CrossRef CAS PubMed.
  89. G. Wang, Y. Wang, Z. Li, H. Li, M. Yu, M. Pang and X. Zhao, Org. Lett., 2022, 24, 9425–9430 CrossRef CAS PubMed.
  90. G. Wang, H. Li, Y. Wang, Z. Li, G. Liu and X. Zhao, Org. Chem. Front., 2023, 10, 5705–5709 Search PubMed.
  91. R. Heinrich, G. Marie-Rose, C. Gourlaouen, P. Pale, E. Brenner and A. Blanc, Chem. -Eur. J., 2025, e202404446 CrossRef CAS.
  92. A. Pradal, Q. Chen, P. F. dit Bel, P. Y. Toullec and V. Michelet, Synlett, 2012, 2012, 74–79 CrossRef.
  93. V. López-Carrillo, N. Huguet, A. Mosquera and A. M. Echavarren, Chem. -Eur. J., 2011, 17, 10972–10978 Search PubMed.
  94. G.-Q. Chen, W. Fang, Y. Wei, X.-Y. Tang and M. Shi, Chem. Sci., 2016, 7, 4318–4328 Search PubMed.
  95. J. P. Reeds, A. C. Whitwood, M. P. Healy and I. J. Fairlamb, Chem. Commun., 2010, 46, 2046–2048 Search PubMed.
  96. P. T. Bohan and F. D. Toste, J. Am. Chem. Soc., 2017, 139, 11016–11019 Search PubMed.
  97. J. Rodriguez and D. Bourissou, Angew. Chem., 2017, 57, 386–388 CrossRef.
  98. C.-Y. Wu, T. Horibe, C. B. Jacobsen and F. D. Toste, Nature, 2015, 517, 449–454 CrossRef CAS PubMed.
  99. J. S. Lee, E. A. Kapustin, X. Pei, S. Llopis, O. M. Yaghi and F. D. Toste, Chem, 2020, 6, 142–152 CAS.
  100. M. Koohgard, L. Enders, N. Del Rio, H. Li, F. Moccia, O. Khaled, O. Bistri, J. Helaja, M. Sollogoub and V. Mouriès-Mansuy, Org. Lett., 2024, 26, 5817–5821 CrossRef CAS.
  101. A. Cataffo, M. Peña-López, R. Pedrazzani and A. M. Echavarren, Angew. Chem., Int. Ed., 2023, 62, e202312874 CrossRef CAS PubMed.
  102. K. Wittstein, K. Kumar and H. Waldmann, Angew. Chem., 2011, 39, 9242–9246 Search PubMed.
  103. W. Zang, Y. Wei and M. Shi, Chem. Commun., 2019, 55, 8126–8129 Search PubMed.
  104. X. Chen, A. T. Holm and P. W. H. Chan, Aust. J. Chem., 2020, 73, 1165–1175 CrossRef CAS.
  105. X. Chen, C. A. Baratay, M. E. Mark, X. Xu and P. W. Hong Chan, Org. Lett., 2020, 22, 2849–2853 Search PubMed.
  106. B. Ranieri, C. Obradors, M. Mato and A. M. Echavarren, Org. Lett., 2016, 18, 1614–1617 Search PubMed.
  107. Y.-J. Wang, X.-X. Li and Z. Chen, J. Org. Chem., 2020, 85, 7694–7703 CrossRef CAS.
  108. C. A. Witham, P. Mauleón, N. D. Shapiro, B. D. Sherry and F. D. Toste, J. Am. Chem. Soc., 2007, 129, 5838–5839 Search PubMed.
  109. L. Ricard and F. Gagosz, Organometallics, 2007, 26, 4704–4707 Search PubMed.
  110. D. Qian and J. Zhang, Chem. Commun., 2011, 47, 11152–11154 Search PubMed.
  111. D. Vasu, H.-H. Hung, S. Bhunia, S. A. Gawade, A. Das and R.-S. Liu, Angew. Chem., Int. Ed., 2011, 50, 6911–6914 Search PubMed.
  112. A. Homs, M. E. Muratore and A. M. Echavarren, Org. Lett., 2015, 17, 461–463 Search PubMed.
  113. K.-B. Wang, R.-Q. Ran, S.-D. Xiu and C.-Y. Li, Org. Lett., 2013, 15, 2374–2377 CrossRef CAS.
  114. H. H. Hung, Y. C. Liao and R. S. Liu, Adv. Synth. Catal., 2013, 355, 1545–1552 CrossRef CAS.
  115. S. Ferrer and A. M. Echavarren, Angew. Chem., 2016, 128, 11344–11348 CrossRef.
  116. S. Ferrer and A. M. Echavarren, Synthesis, 2019, 51, 1037–1048 CrossRef CAS.
  117. W. Fang, X.-Y. Tang and M. Shi, RSC Adv., 2016, 6, 40474–40479 Search PubMed.
  118. B. Jiang, Y. Wei and M. Shi, Org. Chem. Front., 2018, 5, 2091–2097 RSC.
  119. Z.-Z. Zhou, Y.-J. Wang, Q. Zou and Z. Chen, Tetrahedron Lett., 2024, 136, 154918 CrossRef CAS.

This journal is © The Royal Society of Chemistry 2025
Click here to see how this site uses Cookies. View our privacy policy here.